Cognito Therapeutics, a pioneering neurotechnology company developing disease-modifying therapies for neurodegenerative diseases, today announced it will present new clinical data from its OVERTURE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback